These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7639408)

  • 21. Epidemiology and control of vancomycin-resistant enterococci in an adult and children's hospital.
    Tucci V; Haran MA; Isenberg HD
    Am J Infect Control; 1997 Oct; 25(5):371-6. PubMed ID: 9343618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vancomycin-resistant enterococci.
    Rubinstein E; Keynan Y
    Crit Care Clin; 2013 Oct; 29(4):841-52. PubMed ID: 24094380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin resistant enterococci healthcare associated infections.
    Orsi GB; Ciorba V
    Ann Ig; 2013; 25(6):485-92. PubMed ID: 24284534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
    Salgado CD
    Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing the Spread of Vancomycin Resistance--A Report from the Hospital Infection Control Practices Advisory Committee prepared by the Subcommittee on Prevention and Control of Antimicrobial-Resistant Microorganisms in Hospitals; comment period and public meeting--CDC. Notice.
    Fed Regist; 1994 May; 59(94):25758-63. PubMed ID: 10136017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units.
    Fridkin SK; Edwards JR; Courval JM; Hill H; Tenover FC; Lawton R; Gaynes RP; McGowan JE;
    Ann Intern Med; 2001 Aug; 135(3):175-83. PubMed ID: 11487484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What is to be done with vancomycin-resistant enterococcal infections?].
    Bonten MJ; Mascini EM; Willems R; Timmer GJ; Gaillard CA; Vandenbroucke-Grauls CM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(53):2545-9. PubMed ID: 11191789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
    Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vancomycin-resistant enterococcus in end-stage renal disease.
    Brady JP; Snyder JW; Hasbargen JA
    Am J Kidney Dis; 1998 Sep; 32(3):415-8. PubMed ID: 9740157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin-resistant enterococci.
    Gin AS; Zhanel GG
    Ann Pharmacother; 1996 Jun; 30(6):615-24. PubMed ID: 8792949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VRE--what every health care provider needs to know.
    Mikos-Schild S
    Todays Surg Nurse; 1998; 20(3):13-6; quiz 40-1. PubMed ID: 10026632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vancomycin-resistant enterococcus: a review from a Singapore perspective.
    Chlebicki MP; Kurup A
    Ann Acad Med Singap; 2008 Oct; 37(10):861-9. PubMed ID: 19037521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of vancomycin-resistant enterococci in the neonatal intensive care unit.
    Singh N; Léger MM; Campbell J; Short B; Campos JM
    Infect Control Hosp Epidemiol; 2005 Jul; 26(7):646-9. PubMed ID: 16092746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin-resistant enterococci (VRE) and the role of the healthcare worker.
    Ott M; Wirick H
    Can Oper Room Nurs J; 2008 Mar; 26(1):21-4, 26-9, 32. PubMed ID: 18444472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci.
    Quale J; Landman D; Atwood E; Kreiswirth B; Willey BM; Ditore V; Zaman M; Patel K; Saurina G; Huang W; Oydna E; Burney S
    Am J Infect Control; 1996 Oct; 24(5):372-9. PubMed ID: 8902112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections.
    Kauffman CA
    J Antimicrob Chemother; 2003 Jun; 51 Suppl 3():iii23-30. PubMed ID: 12801939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin-resistant enterococcal infections in Korea.
    Kim JM; Song YG
    Yonsei Med J; 1998 Dec; 39(6):562-8. PubMed ID: 10097684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vancomycin resistant Enterococci (VRE)].
    Lesens O
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S261-4. PubMed ID: 19596346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiBAlert-a new information tool to fight multidrug-resistant bacteria in the hospital setting.
    Olesen B; Anhøj J; Rasmussen KP; Mølbak K; Voldstedlund M
    Int J Med Inform; 2016 Nov; 95():43-48. PubMed ID: 27697231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observations on the risk of resistance with the extended use of vancomycin.
    McManus AT; Goodwin CW; Pruitt BA
    Arch Surg; 1998 Nov; 133(11):1207-11. PubMed ID: 9820352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.